![](https://webarchive.library.unt.edu/eot2008/20090514060339im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20090514060339im_/http://www.cancer.gov/images/spacer.gif)
| A drug used to
treat advanced kidney cancer and a type of liver cancer
that cannot be removed by surgery. It is also being studied
in the treatment of other types of cancer.
BAY 43-9006 stops cells from
dividing and may prevent the growth of new blood vessels
that tumors need to grow. It is a type of kinase inhibitor
and a type of antiangiogenesis agent. Also called Nexavar, sorafenib, and sorafenib tosylate. |
Previous Definitions: | baseline, basophil, batimastat, batracylin, BAY 12-9566 | Next Definitions: | BAY 56-3722, BAY 59-8862, BB-10901, BBBD, BBIC |
|
![](https://webarchive.library.unt.edu/eot2008/20090514060339im_/http://www.cancer.gov/images/spacer.gif) |